Iron accumulation is a common feature of aggressive tumors [6] and consistent with this posit, it has been previously established that glioblastoma tumors have increased iron content along with increased expression of transferrin receptor (TfR) and ferritin heavy chain (FtH) relative to normal brain tissue, which is associated with worse clinical outcomes [7,8,9]. This evidence concerns the gene TFRC and glioblastoma.